SCHEMBL9780280

SCHEMBL9780280

COC(=O)CC(=O)Cc1ccc(SC)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SLC6A4 P31645 6/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 2/20 0.41
GFER P55789 1/20 0.41
PLK1 P53350 1/20 0.41
EPHX2 P34913 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1551331 0.87 CYP4F2 (0.59) CYP4F2CYP4A11ALDH1A1KDM4ELMNA
SCHEMBL6068538 0.85 ALDH1A1 (0.59) CYP4F2CYP4A11ALDH1A1KDM4ELMNA
SCHEMBL10695731 0.82 MMP12 (0.45) ALDH1A1KDM4ELMNATSHRHSD17B10
SCHEMBL5802908 0.80 CA2 (0.50) CYP4F2CYP4A11ALDH1A1KDM4ELMNA
SCHEMBL6795893 0.80 TDP1 (0.50) CYP4F2CYP4A11ALDH1A1LMNASMN1; SMN2
SCHEMBL10140460 0.80 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1KDM4ELMNA
SCHEMBL10829361 0.79 CYP4F2 (0.49) CYP4F2CYP4A11ALDH1A1KDM4ELMNA
SCHEMBL6025472 0.79 ALDH1A1 (0.56) CYP4F2CYP4A11ALDH1A1LMNATSHR
SCHEMBL754043 0.79 KMT2A (0.51) CYP4F2CYP4A11KDM4ELMNASMN1; SMN2
SCHEMBL27348043 0.79 LOXL2 (0.55) CYP4F2CYP4A11ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990526-A Skin disorders, antiallergens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1991-02-05 US disclosed
EP-0206741-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1986-12-30 EP disclosed